title: Quantitative MRI in muscular dystrophy: An indispensable trial endpoint?
authors.affiliation: From the Newcastle Magnetic Resonance Centre, Institute of Cellular Medicine, Newcastle University, UK. Kieren.hollingsworth@ncl.ac.uk.
authors.forename: Kieren G
authors.initials: KG
authors.lastname: Hollingsworth
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D007866:Leg; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects*; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents